Login
Create Account

Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

Sabra Healthcare REIT, Inc. SBRA

Real Estate — Reit Healthcare Facilities
Dividend Champion (5y)
Growth Flags show if company had growth for consecutive years

We limit data available in the Overview Report for users who do not have Powerpack

Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.
Register an account and get your Powerpack now or Login

Insider Decisions

Total sells
4.47
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell — — — — — 1 — — — — — 1
Insider Ownership
0.59%

Capital & Financial Ratios

Market Cap
5,150.00
Revenue
859.56
Net Income
65.23
Free Cash Flow
(277.23)
Net Debt
2,387.82
Current Ratio
3.07
Debt/Equity
0.95
P/E ratio
75.92
P/S ratio
5.79
P/B ratio
1.81
Past 5Y EPS Growth
7.91%
This Y EPS Growth
(26.49%)
Next Y EPS Growth
62.74%
Next 5Y EPS Growth
8.62%
in millions of $

Dividends

Payout Ratio
6.32
Annual Dividend Rate
1.20
Annual Dividend Yield
8.95%
total individual payouts
2028 ‡‡‡‡
2027 ‡‡‡‡‡
2026 1.20
—
—
—
2025 1.20
—
—
—
—
2024 1.20
—
—
—
—
2023 1.20
—
—
—
—
2022 1.20
—
—
—
—
2021 1.20
—
—
—
—
2020 1.35
—
—
—
—
2019 1.80
—
—
—
—
2018 1.80
—
—
—
—
2017 2.16
—
—
—
—
—
2016 1.67
—
—
—
—
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 46.72 66.34 78.14 238.34
Receivables — — — —
Inventory — — — —
Other — — — —
467.34 508.92 512.24 353.42
2023 2024 2025 Q'26
Payables 136.98 117.90 119.33 114.95
ST’ Debt — — — —
Other — — — —
136.98 117.90 119.33 114.95
in millions of $

Compound Annual Growth

10y 5y 3y
Sales ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Cash Flow ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Earnings ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡
Book Value ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡

Revenue

Mar Jun Sep Dec Year
’26 221.75 235.87 — —
—
’25 183.54 189.15 190.04 211.90
774.63
’24 166.75 176.14 178.00 182.35
703.24
’23 161.32 161.17 161.63 163.40
647.51
’22 163.11 155.96 140.76 164.99
624.81
’21 152.37 152.93 128.59 135.66
569.55
’20 149.35 153.92 143.25 152.05
598.57
in millions of $

Operating Cash Flow

Mar Jun Sep Dec Year
’26 98.36 85.82 — —
—
’25 80.26 80.96 99.96 87.43
348.61
’24 52.80 80.13 97.65 79.97
310.54
’23 68.29 70.33 83.22 78.74
300.57
’22 63.11 76.57 108.46 67.59
315.73
’21 68.53 83.74 106.19 97.93
356.39
’20 74.82 93.79 96.85 89.40
354.85
in millions of $

Free Cash Flow

Mar Jun Sep Dec Year
’26 (9.59) (123.92) — —
—
’25 64.63 21.89 (107.99) (35.73)
(57.20)
’24 39.86 37.73 42.11 95.70
215.40
’23 161.38 68.52 136.74 18.18
384.81
’22 31.74 67.88 30.74 126.01
256.36
’21 32.25 44.56 105.33 132.88
315.01
’20 1.86 63.45 83.54 82.46
231.30
in millions of $

EPS

Mar Jun Sep Dec Year
’26 0.16 (0.10) — —
—
’25 0.17 0.27 0.09 0.11
0.64
’24 0.11 0.10 0.13 0.19
0.54
’23 (0.04) 0.09 (0.07) 0.07
0.06
’22 0.18 0.07 (0.22) (0.37)
(0.34)
’21 0.16 (0.61) 0.05 (0.11)
(0.52)
’20 0.17 0.14 0.18 0.18
0.67

Target Price Range

High
‡‡‡‡‡
‡‡‡‡
Average
‡‡‡‡‡
‡‡‡‡
Low
‡‡‡‡‡
‡‡‡‡

Recommendation Rating

2.2
1
Buy
2
3
Hold
4
5
Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡ ‡‡‡‡‡ 11.44 10.08 12.83 15.60 — — —
Low Price
‡‡‡‡ ‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 16.60 14.82 20.03 19.97 — — —
High Price
‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ 42 48 50 58 — — —
Employees
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 14.88 13.49 14.06 13.36 — — —
Revenue/Emp
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 624.81 647.51 703.24 774.63 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue
‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ ‡‡‡ 100.00% 100.00% 100.00% 100.00% — — —
Gross Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 21.67 18.66 128.11 153.42 — — —
EBT
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 3.47% 2.88% 18.22% 19.81% ‡‡‡ ‡‡‡ ‡‡‡
EBT Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (77.60) 13.76 126.71 155.51 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Net Income
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 187.78 183.09 169.62 187.00 — — —
Depreciation
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2.71 2.80 3.01 3.21 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue/Sh
‡‡‡‡ ‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡‡ (0.34) 0.06 0.54 0.64 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Earnings/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.37 1.30 1.33 1.44 — — —
Cash Flow/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (0.26) 0.36 (0.41) (1.68) ‡‡‡ ‡‡‡ ‡‡‡
Capex/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.11 1.66 0.92 (0.24) — — —
Free CF/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 13.23 12.12 11.74 11.70 — — —
Book Value/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 230.95 231.20 233.50 241.31 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Shares
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡ 0.00 283.80 32.07 29.14 ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
PE Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 4.66 5.07 5.75 5.90 ‡‡‡ ‡‡‡ ‡‡‡
PS Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.95 1.17 1.48 1.62 ‡‡‡ ‡‡‡ ‡‡‡
PB Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 8.75 8.72 9.09 9.06 ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
EV/Sales
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 21.33 14.68 29.69 (122.74) — — —
EV/FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 315.73 300.57 310.54 348.61 ‡‡‡ ‡‡‡ ‡‡‡
Op' Cash Flow
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (59.37) 84.24 (95.14) (405.82) ‡‡‡‡‡ ‡‡‡‡‡ —
Capex
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 256.36 384.81 215.40 (57.20) — — —
FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 323.07 330.36 391.03 392.91 — — —
Working Cap'
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2,608.77 2,414.10 2,417.65 2,528.90 — — —
Total Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2,554.84 2,367.38 2,351.31 2,450.76 — — —
Net Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 3,056.40 2,802.53 2,741.29 2,823.79 — — —
Sh' Equity
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (1.32%) 0.25% 2.37% 2.88% — — —
ROA
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.57% 2.50% 2.93% 3.04% — — —
ROIC
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (2.41%) 0.47% 4.57% 5.59% — — —
ROE
predictions in italic, sparklines do not include predictions

Analyst Commentary (Summary)

Sabra Health Care REIT (SBRA) has roared back from COVID-era turbulence, delivering a stellar 2024 with revenue surging 9% to $703 million and net income skyrocketing 822% to $127 million—proof of rock-solid operational efficiencies, sharper rent collections, and a lean team driving $14 million per employee in productivity. This healthcare REIT powerhouse, anchored in skilled nursing, senior housing, and medical offices, boasts triple-net leases yielding steadfast 100% gross margins and a rebounding EBT margin to 18.2%, setting the stage for demographic booms as baby boomers fuel senior care demand.

Looking ahead, analysts forecast a tantalizing 7% revenue CAGR through 2027 to $867 million, EPS climbing to $0.78, and ROE hitting 5.1%, powered by rent escalators, strategic divestitures boosting ROIC 83%, and manageable debt at 0.9x equity. With a juicy 6-7% yield, improving cash flows, and shares trading at a discounted 1.5x book value—plus 40% gains in 2024—SBRA screams undervalued opportunity amid healthcare’s unstoppable tailwinds.

Yet, high rates and tenant risks loom, but SBRA’s deleveraged balance sheet and portfolio upgrades position it for dividend hikes and mid-teens upside to high targets. Dive into the full analysis for the charts, forecasts, and catalysts that make this a must-watch growth play!

Read full commentary →

Sabra Healthcare REIT, Inc. (SBRA) Latest News

News by impact score

Fine-tune

10 Aug

3 transcript www.fool.com, 9:29 PM
Sabra Health Care REIT held Q2 2026 earnings call covering financial results and operational updates. Quarterly earnings details may shift near-term investor views but do not signal major strategic shifts.

4 Aug

3 transcript , 9:00 PM
Sabra Health Care REIT Inc reported strong senior housing performance in its Q2 2026 earnings call. Positive senior housing results signal improved operations likely to influence near-term sentiment and performance.

3 transcript www.marketbeat.com, 3:04 PM
Sabra Healthcare REIT reported Q2 results in its earnings call, covering financial performance, occupancy rates, revenue, expenses and forward guidance for healthcare real estate operations. Quarterly earnings and guidance directly inform near-term financial expectations and investor views on operational trends.

3 transcript app.moby.co, 8:30 AM
Sabra Health Care REIT, Inc. held its Q2 2026 earnings call covering financial results and operational updates. Q2 earnings call delivers financial results and guidance that can moderately shift investor views on performance.

3 Aug

3 , 5:45 PM
Sabra Healthcare REIT (SBRA) beat analyst estimates for Q2 funds from operations and revenue. Quarterly earnings beats deliver moderate short-term market reaction without shifting long-term trajectory.

3 , 4:05 PM
Sabra Healthcare REIT reported second quarter 2026 results and reiterated its 2026 guidance. Quarterly results and guidance updates directly shape near-term investor views on financial performance.

21 Jul

4 , 9:05 AM
Sabra Healthcare REIT issued a business update and raised full-year 2026 guidance. Raising 2026 guidance signals stronger expected results that can materially lift valuation and investor sentiment.

3 www.fool.com, 5:53 PM
Sabra Health Care REIT stock rose sharply on positive developments boosting near-term investor sentiment and trading activity. Single-day stock surge signals moderate short-term sentiment lift without evidence of lasting operational or strategic shifts.

12 Jul

3 www.fool.com, 10:24 PM
Analysis compares Sabra Health Care REIT and Welltower to determine which offers better senior housing investment. Direct comparison to larger peer affects relative investor views on SBRA competitive position.

2 Jun

3 Simply Wall St., 9:08 PM
Recent updates are reshaping Sabra Healthcare REIT investment narrative and outlook. Recent updates moderately alter SBRA operational trajectory and investor positioning.

4 May

4 Simply Wall St., 12:31 AM
Sabra Health Care REIT (SBRA) valuation examined after Q1 results show operational shifts toward senior housing, highlighting portfolio adjustments and future growth potential in aging demographics. Q1 results combined with senior housing strategic shift represent major portfolio reorientation impacting SBRA's long-term valuation and market positioning.

3 May

4 Simply Wall St., 11:12 PM
Sabra Health Care REIT (SBRA) pivots toward senior housing and shifts to higher private pay mix, prompting questions on whether investors should take action. Strategic pivot to senior housing and private pay mix shift signals major changes in operations and revenue model with potential to significantly impact performance and investor sentiment.

1 May

4 GuruFocus.com, 3:17 AM
Sabra Health Care REIT Inc (SBRA) Q1 2026 earnings call highlights strong growth in senior housing sector amid robust financial performance. Strong growth in core senior housing segment during Q1 2026 earnings signals significant positive trajectory for SBRA's market performance.

30 Apr

4 www.marketbeat.com, 10:42 PM
Sabra Healthcare REIT (SBRA) Q1 earnings call highlights key financial results, operational updates, portfolio performance, and forward guidance. Q1 earnings highlights disclose financial metrics and outlook that significantly influence SBRA's valuation and market trajectory.

4 transcript www.fool.com, 2:42 PM
Sabra Healthcare REIT, Inc. (SBRA) released its Q1 2026 earnings call transcript, detailing quarterly financial results, operational updates, and management's outlook. Q1 2026 earnings transcript reveals financial performance, guidance, and strategic insights directly impacting SBRA's valuation and market trajectory.

3 app.moby.co, 8:30 AM
Sabra Health Care REIT, Inc. released Q1 2026 earnings call summary detailing quarterly financial performance, operational updates, and forward guidance. Quarterly earnings call summary offers insights into financial results and outlook with moderately noticeable effects on stock performance and investor sentiment.

29 Apr

4 Zacks, 6:40 PM
Sabra Healthcare REIT (SBRA) topped Q1 FFO and revenue estimates. Beating Q1 FFO and revenue estimates boosts SBRA's financial outlook and investor sentiment significantly.

3 Business Wire, 4:05 PM
Sabra Healthcare REIT, Inc. (SBRA) reported first quarter 2026 results and reiterated its full-year 2026 guidance. Quarterly results and unchanged guidance offer moderate visibility into financial stability without signaling major shifts.

16 Apr

4 Simply Wall St., 4:05 PM
Sabra Health Care REIT (SBRA) narrative evolves post-Q4 results and 2026 guidance, highlighting shifts in operational performance, portfolio quality, and long-term outlook amid senior housing and skilled nursing sectors. Q4 earnings and 2026 guidance represent major updates on financial health and future trajectory for SBRA.

3 247wallst.com, 9:37 AM
Most retirees overlook a hidden safety issue in an 8.5% dividend ETF tied to Sabra Healthcare REIT (SBRA), potentially jeopardizing its appeal for income-focused investors. Revealing a hidden safety issue in the high-yield dividend ETF could moderately dent SBRA's market sentiment and dividend attractiveness.

15 Feb

4 Simply Wall St., 4:08 PM
Sabra Health Care REIT (SBRA) shares climbed 6.0% after the company reported 2025 earnings and issued 2026 dividend guidance. Strong 2025 earnings and positive 2026 dividend guidance triggered a 6% stock surge, significantly enhancing investor sentiment and future performance outlook.

13 Feb

4 transcript GuruFocus.com, 8:03 PM
Sabra Healthcare REIT, Inc. (SBRA) reported strong performance in its Q4 2025 earnings call, highlighting robust growth in senior housing and improved occupancy rates. The company emphasized its strategic initiatives aimed at enhancing operational efficiency and expanding its portfolio. Management expressed optimism about future market conditions and the potential for continued revenue growth, driven by demographic trends and increased demand for senior living facilities. Strong performance and strategic initiatives indicate significant potential for future growth and market positioning.

3 transcript www.marketbeat.com, 4:24 PM
Sabra Healthcare REIT, Inc. reported its Q4 earnings, highlighting key financial metrics and operational updates. The company discussed its performance in the healthcare real estate sector, addressing challenges and opportunities in the market. Management provided insights into future strategies and expectations for growth, emphasizing their commitment to enhancing shareholder value. Overall, the earnings call reflected a cautious yet optimistic outlook for the upcoming quarters. Moderate influence on financial performance and market sentiment is expected due to strategic insights shared during the earnings call.

3 transcript www.fool.com, 3:50 PM
Sabra Healthcare REIT, Inc. reported its Q4 2025 earnings, highlighting key financial metrics and operational updates. The company discussed revenue growth, occupancy rates, and strategic initiatives aimed at enhancing portfolio performance. Management provided insights into market conditions and future outlook, emphasizing ongoing efforts to optimize asset management and tenant relationships. Overall, the earnings call reflected a commitment to maintaining stability and growth in a challenging healthcare environment. The earnings report indicates moderate financial performance and strategic initiatives that may influence the company's competitive positioning.

3 transcript app.moby.co, 8:30 AM
Sabra Healthcare REIT, Inc. reported its Q4 2025 earnings, highlighting key financial metrics and operational updates. The company experienced fluctuations in revenue and occupancy rates, impacting overall performance. Management provided insights into strategic initiatives aimed at enhancing portfolio value and addressing market challenges. Future outlook remains cautiously optimistic, with plans for potential acquisitions and investments in healthcare facilities. Fluctuations in revenue and occupancy rates indicate a moderately noticeable influence on financial performance and market sentiment.

12 Feb

3 Associated Press Finance, 5:12 PM
Sabra Healthcare REIT, Inc. reported its Q4 earnings, highlighting key financial metrics and operational performance. The company experienced fluctuations in revenue and occupancy rates, impacting its overall financial outlook. Management provided insights into strategic initiatives and market conditions that may influence future performance. Investors are keenly observing these developments as they assess the company's trajectory in the healthcare real estate sector. Fluctuations in revenue and occupancy rates may moderately influence financial performance and investor sentiment.

3 , 4:05 PM
Sabra Healthcare REIT, Inc. (SBRA) reported its fourth quarter 2025 results, highlighting key financial metrics and operational performance. The company also introduced guidance for 2026, outlining expectations for revenue and earnings growth. Management emphasized strategic initiatives aimed at enhancing portfolio quality and operational efficiency, while addressing market challenges. Overall, the report reflects a commitment to long-term value creation for shareholders. The introduction of 2026 guidance and operational performance insights indicate a moderate influence on future financial performance and market sentiment.

26 Jan

3 Simply Wall St.Simply Wall St.Simply Wall St.Simply Wall St.Simply Wall St.Simply Wall St., 6:16 PM
Sabra Healthcare REIT, Inc. (SBRA) has experienced a strong share price gain over the past three years, raising questions about its current value proposition. Analysts are evaluating whether the stock remains a worthwhile investment given its recent performance and the potential for future growth. Factors influencing this assessment include market conditions, financial health, and strategic initiatives undertaken by the company. Investors are advised to consider these elements when determining the stock's attractiveness in the current environment. The strong share price gain indicates a moderately noticeable influence on investor sentiment and future performance, but other market factors may balance this effect.

15 Jan

3 Yahoo Finance Video, 4:06 PM
Nursing home stocks, including Sabra Healthcare REIT, Inc. (SBRA), have shown signs of recovery since the pandemic, driven by increased demand for skilled nursing facilities and improved occupancy rates. The sector is witnessing a gradual rebound as facilities adapt to new health protocols and address staffing challenges. Investors are cautiously optimistic about the long-term prospects of nursing home stocks, although challenges remain, including regulatory scrutiny and potential changes in reimbursement policies. Overall, the outlook for SBRA and its peers appears to be improving as the industry stabilizes. The recovery in nursing home stocks indicates a moderately noticeable influence on SBRA's financial performance and market sentiment.

16 Nov

3 www.readingeagle.com, 12:21 PM
Sabra Healthcare REIT, Inc. (SBRA) is featured in the Business Weekly Agenda for November 16, highlighting key upcoming events and developments that may influence the company's operations and market position. The agenda outlines important dates and activities relevant to SBRA, providing insights into potential strategic moves and market dynamics affecting the healthcare real estate investment trust sector. Upcoming events may moderately influence Sabra's financial performance and market positioning.
© 2016–2026 stockrow.com Terms and Conditions Indicators Contact Us